MedPath

Vitamin D effect on the HbA1c in diabetic patients

Phase 1
Conditions
Insulin-dependent diabetes mellitus.
Insulin-dependent diabetes mellitus.Without complications
Registration Number
IRCT2013022811799N2
Lead Sponsor
Vice Chancellor for research , School of Medicine, Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
62
Inclusion Criteria

1- All patients aged 7-20 years with type I diabetes 2-Over the past 5 years have diabetes 3- HbA1c level of less than 8 at the time of the study 4-Patients' vitamin D levels measured in the same season.
exclusion criteria: 1-Vitamin D supplementation in the last 6 months in patients 2- Simultaneous presence of associated diseases (hypothyroidism, celiac) 3-Obesity and weight gain in the control group 4-Lack of patient cooperation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1C. Timepoint: Before and after 2 months of intervention. Method of measurement: IU, ELIZA method.
Secondary Outcome Measures
NameTimeMethod
Serum Calcium. Timepoint: before and 2 months after intervention. Method of measurement: mg/dl,Chyme Enzyme method.;Serum Phosphor. Timepoint: before and 2 months after intervention. Method of measurement: mg/dl, Chyme Enzyme method.;Alkalin phosphatase. Timepoint: before and 2 months after intervention. Method of measurement: U/L, Chyme Enzyme method.
© Copyright 2025. All Rights Reserved by MedPath